Hexagon Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,852
| Closed | -$992K | – | 716 |
|
|
2025
Q1 | $992K | Sell |
8,852
-584
| -6% | -$65.4K | 0.19% | 56 |
|
|
2024
Q4 | $872K | Sell |
9,436
-97
| -1% | -$8.96K | 0.16% | 65 |
|
|
2024
Q3 | $799K | Sell |
9,533
-684
| -7% | -$57.3K | 0.16% | 65 |
|
|
2024
Q2 | $701K | Buy |
10,217
+1,506
| +17% | +$103K | 0.15% | 70 |
|
|
2024
Q1 | $638K | Sell |
8,711
-746
| -8% | -$54.6K | 0.14% | 75 |
|
|
2023
Q4 | $766K | Sell |
9,457
-175
| -2% | -$14.2K | 0.18% | 59 |
|
|
2023
Q3 | $722K | Buy |
9,632
+1,218
| +14% | +$91.3K | 0.19% | 51 |
|
|
2023
Q2 | $648K | Sell |
8,414
-403
| -5% | -$31.1K | 0.17% | 55 |
|
|
2023
Q1 | $732K | Buy |
8,817
+8
| +0.1% | +$664 | 0.2% | 47 |
|
|
2022
Q4 | $756K | Sell |
8,809
-2,636
| -23% | -$226K | 0.22% | 45 |
|
|
2022
Q3 | $706K | Buy |
11,445
+6,119
| +115% | +$377K | 0.21% | 53 |
|
|
2022
Q2 | $329K | Buy |
5,326
+1,689
| +46% | +$104K | 0.1% | 123 |
|
|
2022
Q1 | $216K | Buy |
3,637
+1,518
| +72% | +$90.2K | 0.06% | 171 |
|
|
2021
Q4 | $154K | Hold |
2,119
| – | – | 0.04% | 210 |
|
|
2021
Q3 | $148K | Hold |
2,119
| – | – | 0.04% | 192 |
|
|
2021
Q2 | $146K | Buy |
2,119
+200
| +10% | +$13.8K | 0.04% | 191 |
|
|
2021
Q1 | $124K | Buy |
1,919
+500
| +35% | +$32.3K | 0.03% | 194 |
|
|
2020
Q4 | $82K | Sell |
1,419
-300
| -17% | -$17.3K | 0.02% | 215 |
|
|
2020
Q3 | $100K | Buy |
+1,719
| New | +$100K | 0.03% | 176 |
|